Case Control Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Dec 6, 2021; 9(34): 10464-10471
Published online Dec 6, 2021. doi: 10.12998/wjcc.v9.i34.10464
Table 3 Comparison of urinary IgG4 and C5b-9 levels between the two groups (mean ± SD)
Time
Group
Number
IgG4 (ug/mmol)
C5b-9 (ng/mg)
Before treatmentStudy4214.67 ± 2.3983.79 ± 10.66
Control4215.19 ± 2.5385.65 ± 11.20
t0.9680.780
P value0.3360.438
After 12 weeks of treatmentStudy421.45 ± 0.29a44.81 ± 9.39a
Control423.13 ± 0.71a55.37 ± 10.23a
t14.1964.928
P value0.0000.000